Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.

NCT01811056 · ClinicalTrials.gov registry record · NA

Exploring a Patient-centered Approach to Mifepristone Administration in Medical Abortion

A NA study, sponsored by Gynuity Health Projects.

Completed
Registry status
NA
Development phase
401
Enrollment target

NCT01811056 is a NA study that has completed, run by Gynuity Health Projects. The registered enrollment target is 401 participants.

View on ClinicalTrials.gov ↗

View your shortlist →

The verdict

NCT01811056, a NA study, has completed, sponsored by Gynuity Health Projects.

COMPLETED
Registry status
NA
Development phase
401 participants
Enrollment target

Study Summary

This study will test ways to give women more options and flexibility when they are ending their unwanted pregnancies. The investigators will look at uptake and acceptability of using mifepristone outside of the clinic for pregnancy termination.

Interventions

  • DRUG Mifepristone

Trial Details

FieldValue
Enrollment Target 401 participants
Start Date 2013-04
Est. Completion 2014-07
Phase NA

Sponsor

Gynuity Health Projects

29 total trials

What the Registry Record Tells You About NCT01811056

The ClinicalTrials.gov registry entry for NCT01811056 describes a study currently listed as completed, categorized as NA. The registered enrollment target is 401 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is Gynuity Health Projects, which has 29 total studies on file at ClinicalTrials.gov.

The record links to 0 conditions, and to 1 intervention - of which Mifepristone is the first listed.

NCT01811056 reports 0 study locations.

Frequently Asked Questions

What is clinical trial NCT01811056 about?

NCT01811056 is a clinical study titled "Exploring a Patient-centered Approach to Mifepristone Administration in Medical Abortion". This study will test ways to give women more options and flexibility when they are ending their unwanted pregnancies. The investigators will look at uptake and acceptability of using mifepristone outside of the clinic for pregnancy termination.

What is the current status of trial NCT01811056?

This trial is currently completed. It is a NA study. The enrollment target is 401 participants. The study started on 2013-04. Estimated completion is 2014-07.

What interventions are being tested in trial NCT01811056?

The interventions under investigation include: Mifepristone (DRUG).

Who is sponsoring clinical trial NCT01811056?

This trial is sponsored by Gynuity Health Projects, which has 29 total clinical trials registered on ClinicalTrials.gov.

Data sourced from official public datasets. See our methodology for details. Retrieved and formatted by PlainTrial Editorial

Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.